174 related articles for article (PubMed ID: 37382156)
1. International Society of Urological Pathology (ISUP) Consensus Conference on Current Issues in Bladder Cancer. Working Group 2: Grading of Mixed Grade, Invasive Urothelial Carcinoma Including Histologic Subtypes and Divergent Differentiations, and Non-Urothelial Carcinomas.
Paner GP; Kamat A; Netto GJ; Samaratunga H; Varma M; Bubendorf L; van der Kwast TH; Cheng L;
Am J Surg Pathol; 2024 Jan; 48(1):e11-e23. PubMed ID: 37382156
[TBL] [Abstract][Full Text] [Related]
2. International Society of Urological Pathology (ISUP) Consensus Conference on Current Issues in Bladder Cancer. Working Group 1: Comparison of Bladder Cancer Grading System Performance.
Downes MR; Hartmann A; Shen S; Tsuzuki T; van Rhijn BWG; Bubendorf L; van der Kwast TH; Cheng L;
Am J Surg Pathol; 2024 Jan; 48(1):e1-e10. PubMed ID: 37246824
[TBL] [Abstract][Full Text] [Related]
3. Urachal carcinomas of the nonglandular type: salient features and considerations in pathologic diagnosis.
Paner GP; Barkan GA; Mehta V; Sirintrapun SJ; Tsuzuki T; Sebo TJ; Jimenez RE
Am J Surg Pathol; 2012 Mar; 36(3):432-42. PubMed ID: 22301493
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance in substaging ofT1 urinary bladder urothelial carcinoma on transurethral resection.
Chang WC; Chang YH; Pan CC
Am J Surg Pathol; 2012 Mar; 36(3):454-61. PubMed ID: 22261706
[TBL] [Abstract][Full Text] [Related]
5. Comparison of WHO/ISUP and WHO classification of noninvasive papillary urothelial neoplasms for risk of progression.
Samaratunga H; Makarov DV; Epstein JI
Urology; 2002 Aug; 60(2):315-9. PubMed ID: 12137833
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathologic features and prognostic significance of mixed (Low and high-grade) papillary urothelial carcinoma comparison with low and high-grade papillary urothelial carcinoma.
Kir G; Cecikoglu GE; Topal CS; Sorkun MH; Culpan M; Suceken FY; Karaca H; Yildirim A
Virchows Arch; 2023 Nov; 483(5):621-634. PubMed ID: 37632533
[TBL] [Abstract][Full Text] [Related]
7. Histologic grading of noninvasive papillary urothelial tumors: validation of the 1998 WHO/ISUP system by immunophenotyping and follow-up.
Yin H; Leong AS
Am J Clin Pathol; 2004 May; 121(5):679-87. PubMed ID: 15151208
[TBL] [Abstract][Full Text] [Related]
8. Cancer heterogeneity and its biologic implications in the grading of urothelial carcinoma.
Cheng L; Neumann RM; Nehra A; Spotts BE; Weaver AL; Bostwick DG
Cancer; 2000 Apr; 88(7):1663-70. PubMed ID: 10738225
[TBL] [Abstract][Full Text] [Related]
9. Survival following the diagnosis of noninvasive bladder cancer: WHO/International Society of Urological Pathology versus WHO classification systems.
Schned AR; Andrew AS; Marsit CJ; Zens MS; Kelsey KT; Karagas MR
J Urol; 2007 Oct; 178(4 Pt 1):1196-200; discussion 1200. PubMed ID: 17698105
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of minor high grade component in non-invasive papillary urothelial carcinoma of urinary bladder: (A study of 273 consecutive cases over a period of 3 years).
Syed M; Mushtaq S; Loya A; Hassan U; Mir K; Hussain M; Hameed M; Sheikh UN
Ann Diagn Pathol; 2023 Apr; 63():152079. PubMed ID: 36549142
[TBL] [Abstract][Full Text] [Related]
11. International Opinions on Grading of Urothelial Carcinoma: A Survey Among European Association of Urology and International Society of Urological Pathology Members.
Beijert IJ; Cheng L; Liedberg F; Plass K; Williamson SR; Gontero P; Ribal MJ; Babjuk M; Black PC; Kamat AM; Algaba F; Berman DM; Hartmann A; Masson-Lecomte A; Rouprêt M; Lopez-Beltran A; Samaratunga H; Shariat SF; Mostafid AH; Varma M; Shen S; Burger M; Tsuzuki T; Palou J; Compérat EM; Sylvester RJ; van der Kwast TH; van Rhijn BWG; Downes MR
Eur Urol Open Sci; 2023 Jun; 52():154-165. PubMed ID: 37284047
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of a grading system considering tumor heterogeneity in muscle-invasive urothelial carcinoma of the urinary bladder.
Krüger S; Thorns C; Böhle A; Feller AC
Int Urol Nephrol; 2003; 35(2):169-73. PubMed ID: 15072488
[TBL] [Abstract][Full Text] [Related]
13. Assessing the Impact of the Absence of Detrusor Muscle in Ta Low-grade Urothelial Carcinoma of the Bladder on Recurrence-free Survival.
Mastroianni R; Brassetti A; Krajewski W; Zdrojowy R; Salhi YA; Anceschi U; Bove AM; Carbone A; De Nunzio C; Fuschi A; Ferriero M; Nacchia A; Pastore AL; Tema G; Tuderti G; Gallucci M; Simone G
Eur Urol Focus; 2021 Nov; 7(6):1324-1331. PubMed ID: 32900676
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of the 2004 WHO/ISUP classification for prediction of recurrence, progression, and cancer-specific mortality of non-muscle-invasive urothelial tumors of the urinary bladder: a clinicopathologic study of 1,515 cases.
Pan CC; Chang YH; Chen KK; Yu HJ; Sun CH; Ho DM
Am J Clin Pathol; 2010 May; 133(5):788-95. PubMed ID: 20395527
[TBL] [Abstract][Full Text] [Related]
15. Correlation between biopsy and radical cystectomy in assessing grade and depth of invasion in bladder urothelial carcinoma.
Chang BS; Kim HL; Yang XJ; Steinberg GD
Urology; 2001 Jun; 57(6):1063-6; discussion 1066-7. PubMed ID: 11377305
[TBL] [Abstract][Full Text] [Related]
16. Histologic grading of urothelial carcinoma: a reappraisal.
Cheng L; MacLennan GT; Lopez-Beltran A
Hum Pathol; 2012 Dec; 43(12):2097-108. PubMed ID: 22542126
[TBL] [Abstract][Full Text] [Related]
17. Squamous differentiation in patients with superficial bladder urothelial carcinoma is associated with high risk of recurrence and poor survival.
Li G; Yu J; Song H; Zhu S; Sun L; Shang Z; Niu Y
BMC Cancer; 2017 Aug; 17(1):530. PubMed ID: 28789622
[TBL] [Abstract][Full Text] [Related]
18. Differential Expression of PD-L1 in High Grade T1 vs Muscle Invasive Bladder Carcinoma and its Prognostic Implications.
Wankowicz SAM; Werner L; Orsola A; Novak J; Bowden M; Choueiri TK; de Torres I; Morote J; Freeman GJ; Signoretti S; Bellmunt J
J Urol; 2017 Oct; 198(4):817-823. PubMed ID: 28487100
[TBL] [Abstract][Full Text] [Related]
19. Low-grade papillary urothelial carcinoma of the urinary bladder: a clinicopathologic analysis of a post-World Health Organization/International Society of Urological Pathology classification cohort from a single academic center.
Miyamoto H; Brimo F; Schultz L; Ye H; Miller JS; Fajardo DA; Lee TK; Epstein JI; Netto GJ
Arch Pathol Lab Med; 2010 Aug; 134(8):1160-3. PubMed ID: 20670136
[TBL] [Abstract][Full Text] [Related]
20. Contemporary Gleason Grading of Prostatic Carcinoma: An Update With Discussion on Practical Issues to Implement the 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma.
Epstein JI; Amin MB; Reuter VE; Humphrey PA
Am J Surg Pathol; 2017 Apr; 41(4):e1-e7. PubMed ID: 28177964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
